MedPath

effectiveness of Tranexamic acid in blood loss during and after cesarean sectio

Not Applicable
Conditions
caesarean section.
Single delivery by caesarean section
Registration Number
IRCT2014100419396N1
Lead Sponsor
Hormozgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

All women between 20 to 40 years of age who were in their 37th to 40th week of pregnancy and had opted for a cesarean surgery entered the study.
The following were excluded: those with an experience of twinning; placenta abnormalities; severe pre-eclampsia; macrosomy; polyhydramnios; previous cesarean or abdominal surgeries; kidney, brain, blood or liver disorders, coagulopathy; anemia; thrombophilia; thromboembolic disorders; allergy to Tranexamic acid. In addition, patients whose BMI was higher than 30 were excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of the blood loss. Timepoint: The amount of the blood lost would be estimated 2 hours after the delivery (based on the difference of the weight of the tampon used). At the outset of the surgery, a tampon would be inserted into the vagina, the difference of its weight before the surgery and 2 hours after the surgery will be calculated. Method of measurement: The amount of blood loss would be estimated through Gai et al.’s method:.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath